Work

Tolerability and effectiveness of pertuzumab-containing neoadjuvant (NA) regimens vs. AC-TH for HER2-positive (+) localized breast cancer (BC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.586

Authors: Laura Spring, Andrzej Niemierko, Amy H. Comander, Kerry Lynn Reynolds, Susan A. Sajer, Jennifer Shin, Elena F Brachtel, Michelle Connolly Specht, Barbara L. Smith, Alphonse G. Taghian, Jeffrey M. Peppercorn, Steven J. Isakoff, Beverly Moy, Aditya Bardia

Institution: Massachusetts General Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2632016692

Cites:

Cited by: 1

Related to: 10